- Irwin Naturals (IWIN) has released its new CBD 25mg softgels in Canada
- The softgels are available nationwide through the Starseed Medicinal Medical Group platform
- This is the first of five CBD and THC products that the company plans to launch nationwide over the next few months through its licensing agreement with Entourage Health Corp. (TSXV:ENTG)
- Irwin Naturals (IWIN) opened trading at $2.70
Irwin Naturals (IWIN) has released its new CBD 25mg softgels in Canada.
The softgels are available nationwide through the Starseed Medicinal Medical Group platform and are the first of five CBD and THC products that the company plans to launch nationwide over the next few months through its licensing agreement with Entourage Health Corp. (TSXV:ENTG).
The full line of Irwin Naturals Cannabis products will be offered as softgels that utilize hemp seed oil and medium-chain triglyceride (MCT) oil. There will be five different formulations: THC (10 mg THC), CBD (25 mg CBD), 1:1 (10 mg CBD, 10 mg THC), 3:1 (30 mg CBD, 10 mg THC) and a 2:1 formulation that combines THC and the cannabinoid CBN (10 mg THC, 5 mg CBN).
Klee Irwin, CEO of Irwin Naturals commented on the news,
“With our CBD 25mg softgels, we are bringing a high-quality cannabis-derived CBD oil product to allow consumers to incorporate premium CBD into their daily health regimens.”
Irwin Naturals develops vitamins and other health supplements and distributes these products in the United States and Canada. It is leveraging its household name to enter into the cannabis and psychedelic sectors.
Irwin Naturals (IWIN) opened trading at $2.70.
